Noven's Stavzor receives tentative FDA approval

12/26/2007 | Boston Globe (tiered subscription model), The · CNNMoney

Noven Pharmaceuticals announced the FDA granted tentative approval for Stavzor as treatment for manic episodes connected to bipolar disorder, epilepsy and migraine headaches. The Miami-based firm also said it expects final FDA approval to market Stavzor in the U.S. by the end of July 2008, after a similar drug from Abbott Laboratories, Depakote, loses exclusivity rights.

View Full Article in:

Boston Globe (tiered subscription model), The · CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA